Biopsy Devices Market Analysis and Forecast 2021-2026
The global biopsy devices market size is expected to reach US$ 2.87 Billion by 2026, exhibiting a CAGR of 5.12% during 2021-2026, according to the latest report by IMARC Group.
Biopsy devices assist surgeons, cardiologists and other medical practitioners in performing the surgical removal of tissues from any part of the body to examine the presence of a disease. They are also utilized for surgically removing a suspicious nodule or lump with the help of ultrasound, x-ray, computed tomography (CT), or magnetic resonance imaging (MRI). These imaging techniques determine precisely where the needle needs to be placed for performing the biopsy.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request for a sample copy of this report: https://www.imarcgroup.com/biopsy-devices-market/requestsample
Global Biopsy Devices Market Trends:
According to the World Health Organization (WHO), cancer is one of the leading causes of death and resulted in around 9.6 million deaths across the globe in 2018. The increasing prevalence of the disease represents one of the significant factors strengthening the biopsy devices market growth. Apart from this, the increasing awareness among individuals about the availability of diagnostic and screening procedures for chronic diseases is positively influencing the demand for integrated technologies, such as stereotactic-guided biopsies. Furthermore, the development of vacuum-assisted guns and smart biopsy systems are helping in distinguishing healthy cells from tumorous ones. Some of the other factors anticipated to bolster the market growth in the upcoming years are the growing geriatric population, rising healthcare expenditure, increasing initiatives undertaken by governing agencies of various countries and extensive research and development (R&D) activities.
Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being
Argon Medical Devices Inc.,
B. Braun Melsungen,
Becton,
Dickinson and Company,
Boston Scientific Corporation,
Cardinal Health Inc.,
Cook Group Incorporated,
Danaher Corporation,
Hologic Inc.,
Medtronic Inc., etc.
View Report TOC, Figures and Tables: https://www.imarcgroup.com/biopsy-devices-market
Insights on Market Segmentation:
Breakup by Procedure Type:
- Surgical Biopsy
- Needle Biopsy
Breakup by Product:
- Needle-based Biopsy Instruments
- Core Biopsy Devices
- Aspiration Biopsy Needles
- Vacuum-assisted Biopsy Devices
- Localization Wires
- Procedure Trays
- Others
Breakup by Application:
- Breast Biopsy
- Lung Biopsy
- Colorectal Biopsy
- Prostate Biopsy
- Others
Breakup by Guidance Technique:
- Ultrasound Guided Biopsy
- Stereotactic Guided Biopsy
- MRI Guided Biopsy
- Others
Breakup by End-User:
- Hospitals and Clinics
- Academic and Research Institutes
- Others
Breakup by Region:
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East and Africa
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us
30 N Gould St
Ste R
Sheridan, WY 82801
USA
Email: sales@imarcgroup.com
Website: https://www.imarcgroup.com
Follow us on twitter: @imarcglobal
